These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 26686578)

  • 1. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
    Chufan EE; Kapoor K; Ambudkar SV
    Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.
    Vahedi S; Chufan EE; Ambudkar SV
    Biochem Pharmacol; 2017 Nov; 143():53-64. PubMed ID: 28728917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions.
    Shukla S; Abel B; Chufan EE; Ambudkar SV
    J Biol Chem; 2017 Apr; 292(17):7066-7076. PubMed ID: 28283574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-dependent thermostabilization of human P-glycoprotein (ABCB1) is blocked by modulators.
    Lusvarghi S; Ambudkar SV
    Biochem J; 2019 Dec; 476(24):3737-3750. PubMed ID: 31774117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.
    Ledwitch KV; Gibbs ME; Barnes RW; Roberts AG
    Biochem Pharmacol; 2016 Oct; 118():96-108. PubMed ID: 27531061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the multidrug resistance modulators tariquidar and elacridar and their analogues with P-glycoprotein.
    Pajeva IK; Sterz K; Christlieb M; Steggemann K; Marighetti F; Wiese M
    ChemMedChem; 2013 Oct; 8(10):1701-13. PubMed ID: 23943604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis reveals the importance of residues of the access tunnel inhibitor site to human P-glycoprotein (ABCB1)-mediated transport.
    Salazar PB; Murakami M; Ranganathan N; Durell SR; Ambudkar SV
    Protein Sci; 2024 Sep; 33(9):e5155. PubMed ID: 39194126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
    Chufan EE; Kapoor K; Sim HM; Singh S; Talele TT; Durell SR; Ambudkar SV
    PLoS One; 2013; 8(12):e82463. PubMed ID: 24349290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1).
    Pluchino KM; Hall MD; Moen JK; Chufan EE; Fetsch PA; Shukla S; Gill DR; Hyde SC; Xia D; Ambudkar SV; Gottesman MM
    Biochemistry; 2016 Feb; 55(7):1010-23. PubMed ID: 26820614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1).
    Sajid A; Lusvarghi S; Chufan EE; Ambudkar SV
    PLoS One; 2018; 13(9):e0204693. PubMed ID: 30265721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
    Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
    J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors.
    Dastvan R; Mishra S; Peskova YB; Nakamoto RK; Mchaourab HS
    Science; 2019 May; 364(6441):689-692. PubMed ID: 31097669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiol-reactive drug substrates of human P-glycoprotein label the same sites to activate ATPase activity in membranes or dodecyl maltoside detergent micelles.
    Loo TW; Clarke DM
    Biochem Biophys Res Commun; 2017 Jul; 488(4):573-577. PubMed ID: 28533092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.
    Li MJ; Nath A; Atkins WM
    Biochemistry; 2017 May; 56(19):2506-2517. PubMed ID: 28441502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the Interaction of A
    Abel B; Tosh DK; Durell SR; Murakami M; Vahedi S; Jacobson KA; Ambudkar SV
    Mol Pharmacol; 2019 Aug; 96(2):180-192. PubMed ID: 31127007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.
    Zoghbi ME; Mok L; Swartz DJ; Singh A; Fendley GA; Urbatsch IL; Altenberg GA
    J Biol Chem; 2017 Dec; 292(50):20412-20424. PubMed ID: 29018094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the brain distribution of imatinib and its metabolites in mice by valspodar, zosuquidar and elacridar.
    Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
    Pharm Res; 2007 Sep; 24(9):1720-8. PubMed ID: 17380257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.
    Kluth M; Stindt J; Dröge C; Linnemann D; Kubitz R; Schmitt L
    J Biol Chem; 2015 Feb; 290(8):4896-4907. PubMed ID: 25533467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
    Sajid A; Raju N; Lusvarghi S; Vahedi S; Swenson RE; Ambudkar SV
    Drug Metab Dispos; 2019 Oct; 47(10):1013-1023. PubMed ID: 31371421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.